Skip to main content
. 2025 May 15;99(1):254–262. doi: 10.1038/s41390-025-04094-x

Table 4.

Primary and secondary outcomes of completed participants with end study data.

Control group completed start and end surveys (N = 8) Intervention group completed start and end surveys (N = 12) P-value
Change in VBSc Score over time overall, median (IQR) 0.0 (−4.0, 0.75) −6.0 (−8.5, −4.5) 0.07+
Change in VCSc Score over time overall, median (IQR) 0.0 (−4.75, 2.25) −0.5 (−3.75, 3.75) 1.00
Change in RVCSc Score over time overall, median (IQR) 0.0 (−13.0, 6.0) −17.0 (−22.0, 0.0) 0.27
Change in BDI-II Score over time overall, median (IQR) 0.0 (−5.0, 0.0) −5.0 (−8.0, −0.5) 0.38
Change in BAI Score over time overall, median (IQR) −4.0 (−9.0, 0.0) −2.0 (−10.0, 5.25) 0.65
Change in TEQ over time overall, median (IQR) −2.0 (−10.0, 5.25) 0.0 (−1.0, 0.0) 0.30
Parental Suicidality occurrences, N (%) 0 (0) 0 (0) NA
Infant death, N (%) 0 (0) 0 (0) NA

VBSc Vulnerable Baby Scale, VCSc Vulnerable Child Scale, RVCSc Revised Vulnerable Child Scale, BDI-II Beck Depression Inventory 2nd Edition, BAI Beck Anxiety Inventory, TEQ Traumatic Event Questionnaire, IQR Interquartile range.

None of the variables differed significantly between groups; p-value of <0.05 considered significant. + Post-hoc analysis of VBSc score change over time for primary outcome was conducted using the Bayesian multinomial ordinal model. Good convergence was obtained after merging patients into five groups. Bayesian analysis with a neutral prior indicated that the 5th centile of the posterior odds ratio (treatment vs control) was 1.25. Thus, there was 95% chance that the treatment group did better than the control.